2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Role of metformin in diabetic aging female rat brain: a future therapy for neurodegenerative diseases

P. Kumar, N. Baquer (New Delhi, India)
Role of microglia in the transmission of α-syn-containing exosomes

Y. Xia, G. Zhang, J. Huang, N. Xiong, K. Ma, X. Guo, F. Wan, L. Kou, S. Yin, T. Wang (Wuhan, China)
Role of Sex on Cholinergic Activity and Attention in Parkinson’s disease

D. Martini, R. Morris, T. Madhyastha, T. Grabowski, J. Quinn, F. Horak (Portland, OR, USA)
Role of uric acid as a prognostic biomarker in Idiopathic Parkinson’s disease and Parkinson Plus Syndrome

T. Modi, M. Goyal, J. Kaur, B. Medhi (Chandigarh, India)
Rose Anthocyanins protect against Parkinson’s pathophysiology: Behavioral and biochemical changes in young Drosophila

G. Chandran, P. Chandrashekar, M. Jayaraju, J. Chauhan (Mysuru, India)
Rotenone model of Parkinson’s disease: The dosing options in mice revisited

M. Raza, N. Zehra, S. Malhi (Karachi, Pakistan)
Rotigotine protects dopaminergic neurons by targeting serotonin 1A receptors on astrocytes

M. Asanuma, I. Miyazaki, N. Isooka, R. Kikuoka, K. Wada, E. Nakayama, K. Shin, D. Yamamoto, Y. Kitamura (Okayama, Japan)
Saccades in Parkinson’s disease: Hypometric, slow, or maladaptive?

L. Neilson, F. Ghasia, A. Shaikh (Cleveland, OH, USA)
Safety and efficacy of high definition tDCS for proprioception and balance in Parkinson’s disease: A pilot randomised trial

H. Teasdale, E. Preston, A. Flood, G. Waddington (Canberra, Australia)
Safety and Efficacy of Levodopa-Carbidopa Monotherapy in Patients with Advanced Parkinson’s Disease

J. Boyd, C. Zadikoff, M. Siddiqui, J. Benesh, J. Zamudio, W. Robieson, P. Kukreja (Burlington, VT, USA)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z